Company / Assets per Share
Ovid Therapeutics Inc. Assets per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$2.13
FY2025
5-year range
$1.30 / $2.21
FY2022-FY2025
Trend
+63.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Assets per Share returned to growth in FY2025 after 2 years of decline, reaching $2.13.
Based on SEC 10-K filings.
2.13 in FY2025 with a 3-year CAGR of -1.2%.
Improved from $2.04 to $2.13 over the past 2 years.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -1.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, assets per share increased 63.0% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.61 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.13 | +63.0% |
| FY2024 | $1.30 | -36.2% |
| FY2023 | $2.04 | -7.4% |
| FY2022 | $2.21 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026